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Background: Peripartum cardiomyopathy (PPCM) describes dilated cardiomyopathy (DCM) that occurs during or after pregnancy. PPCM has been 
formally restricted to DCM onset during the last month of pregnancy or 5 months postpartum. Pregnancy associated cardiomyopathy (PACM), a 
related term, refers to onset occurring before the last month of pregnancy. Multiple PPCM studies have focused on inflammatory, immunologic and 
environmental etiologies. An alternative hypothesis is that PPCM and PACM result from genetic cause.
Methods: A systematic search of our family-based DCM database designed for genetic studies was undertaken for cases associated with pregnancy 
and the postpartum period. In the identified cases, clinical and molecular genetic data, including exonic and near intron/exon boundaries of 14 
genes (CSRP3, LDB3, MYH7, SCN5A, TCAP, TNNT2, LMNA, PSEN1, PSEN2, MYBPC3, MYH6, TNNIC, TNNI3, and TPM) were analyzed.
Results: We identified 37 of 4006 females with evidence of PPCM/PACM, of which 17 had clinical and genotype data available for analysis; 12 met 
criteria for PPCM, and 2 had PACM. The median age of onset was 28 years; 13 presented heart failure. Evidence for DCM included left ventricular 
dilatation with an echocardiographically-derived mean left ventricular end-diastolic dimension Z score of 4.24, and a mean ejection fraction of 
26.5%. Protein-altering variants in 7 genes (MYBPC3-R272C, MYH7-G1808A, TNNT2-R159Q, MYH6-R568C, SCN5A-R222Q, PSEN1-D333G, PSEN2-
S130L) were identified in 7 of the 17 genotyped cases (41%); 6 had PPCM, and one had PACM. Five of the seven had at least one family member 
with DCM; 2 were apparently sporadic. One of the sporadic cases had PPCM. The mutations in MYBPC3, MYH7, TNNT2, MYH6, and SCN5A, or PSEN1 
and PSEN2 were absent in 253 or 413 controls, respectively. All mutations (except MYBPC3-R272C, which has been reported with DCM) were novel. 
Functional studies in cardiac myocytes reconstituted with TNNT2 R159Q mutant protein showed decreased Ca2+ sensitivity of force development. 
The presenilin and SCN5A mutations segregated with DCM.
Conclusions: These findings suggest that rare DCM variant mutations may contribute to PPCM/PACM.
